Skip to content
Trending storyDeveloping

A fatal reaction: A cutting-edge gene-editing trial in China went disastrously wrong. A family wants accountability

2 reports1 sourceupdated 3 hours ago

Start here

No synthesis yet — start with the coverage timeline below.

Coverage timeline

Follow the coverage to see the different angles.

Heat trend for this story

Not enough continuous observation yet to draw a trend.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org